180 Life Sciences Corp (ATNF)
2.20
-0.08
(-3.51%)
USD |
NASDAQ |
Nov 22, 09:45
180 Life Sciences Price to Book Value: 1.165 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 21, 2024 | 1.207 |
November 20, 2024 | 1.239 |
November 19, 2024 | 1.244 |
November 18, 2024 | 1.223 |
November 15, 2024 | 1.324 |
November 14, 2024 | 1.419 |
November 13, 2024 | 1.530 |
November 12, 2024 | 1.578 |
November 11, 2024 | 1.753 |
November 08, 2024 | 1.536 |
November 07, 2024 | 1.551 |
November 06, 2024 | 1.604 |
November 05, 2024 | 1.678 |
November 04, 2024 | 1.811 |
November 01, 2024 | 1.980 |
October 31, 2024 | 2.076 |
October 30, 2024 | 1.081 |
October 29, 2024 | 1.218 |
October 28, 2024 | 1.163 |
October 25, 2024 | 1.172 |
October 24, 2024 | 1.067 |
October 23, 2024 | 1.169 |
October 22, 2024 | 1.290 |
October 21, 2024 | 1.367 |
October 18, 2024 | 1.383 |
Date | Value |
---|---|
October 17, 2024 | 1.191 |
October 16, 2024 | 1.779 |
October 15, 2024 | 0.418 |
October 14, 2024 | 0.374 |
October 11, 2024 | 0.363 |
October 10, 2024 | 0.3603 |
October 09, 2024 | 0.3768 |
October 08, 2024 | 0.3245 |
October 07, 2024 | 0.385 |
October 04, 2024 | 0.3905 |
October 03, 2024 | 0.3795 |
October 02, 2024 | 0.3878 |
October 01, 2024 | 0.4235 |
September 30, 2024 | 0.4593 |
September 27, 2024 | |
September 26, 2024 | |
September 25, 2024 | |
September 24, 2024 | |
September 23, 2024 | |
September 20, 2024 | |
September 19, 2024 | |
September 18, 2024 | |
September 17, 2024 | |
September 16, 2024 | |
September 13, 2024 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1226
Minimum
Dec 22 2022
122.50
Maximum
Jul 12 2021
8.749
Average
1.546
Median
Aug 31 2020
Price to Book Value Benchmarks
Seelos Therapeutics Inc | -- |
NovaBay Pharmaceuticals Inc | 3.213 |
Palatin Technologies Inc | -- |
iBio Inc | 1.252 |
Theriva Biologics Inc | 0.1469 |
Price to Book Value Related Metrics
Price | 2.20 |
Earnings Yield | -218.9% |
Market Cap | 4.349M |